Skip to main content
. 2020 Mar 16;26:102248. doi: 10.1016/j.nicl.2020.102248

Table 2.

AUCs for All Classification Models in Test and Clinical Cohorts.

Model: Test Cohort AUCs (95% CI) Clinical Cohort AUCs (95% CI)
Age 0.675 0.742
(0.572–0.778) (0.694–0.790)
HCV 0.944 0.801
(0.902–0.987) (0.756–0.846)
SARA 0.961 0.820
(0.925–0.997) (0.776–0.864)
HCV + Age 0.950 0.792
(0.909–0.991) (0.747–0.838)
SARA + Age 0.962 0.799
(0.924–0.999) (0.753–0.845)
HCVadj 0.948 0.743
(0.905–0.992) (0.693–0.792)
SARAadj 0.952 0.764
(0.911–0.993) (0.714–0.813)
HCVadj + Age 0.949 0.793
(0.908–0.991) (0.748–0.840)
SARAadj + Age 0.961 0.799
(0.925–0.997) (0.752–0.845)

Table 2 displays each model's AUC (for AD vs. non-AD diagnoses) in the Test Cohort and Clinical Cohort along with its associated 95% CI. The AUC of an ROC plot (not displayed) gives a measure of model performance that does not depend on a specific cut-off or threshold. The various SARA models include hippocampal volume, inferior lateral ventricle volume, entorhinal thickness, amygdala volume, and inferior parietal thickness. X + Age indicates model X with age added as a covariate; Xadj indicates Model X using volumes and cortical thicknesses that have been adjusted for age-related atrophy.

Abbreviations: AD – Alzheimer disease; AUC – Receiver Operating Characteristics Area Under the Curve; CI – Confidence Interval; HCV – Hippocampal Volume; SARA – Select Atrophied Regions in Alzheimer disease